FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA OKs Keytruda Pleural Mesothelioma Indication

FDA approves an additional indication for Mercks Keytruda with chemotherapy to treat unresectable advanced or metastatic malignant pleural mesotheliom...

latest-news-card-1
Human Drugs

Bill Introduced on Generic Drug Prompt Approvals

Congresswoman Nanette Barragn (D-CA) reintroduces the Prompt Approval of Safe Generic Drugs Act, legislation that would remove hurdles in the ANDA app...

latest-news-card-1
Human Drugs

FDA Review of Govorestat on Track: Company

FDA tells Applied Therapeutics its govorestat is on track for the 11/28 PDUFA action date and will not need to go before an advisory committee.

latest-news-card-1
Medical Devices

Smiths Medical Recalls Bivona Tracheostomy Tubes

Smiths Medical recalls (Class 1) several lots of its Bivona Neonatal/Pediatric and Adult Tracheostomy tubes due to a manufacturing defect.

latest-news-card-1
Biologics

Fasenra OKd for Rare Vasculitis

FDA approves AstraZenecas Fasenra (benralizumab) for treating adult patients with eosinophilic granulomatosis with polyangiitis.

latest-news-card-1
Federal Register

Integrating Trials into Clinical Practice Guide

Federal Register notice: FDA makes available a draft guidance entitled Integrating Randomized Controlled Trials for Drug and Biological Products into ...

latest-news-card-1

Decentralized Clinical Trial Guidance

FDA publishes a guidance on the conduct of clinical trials with decentralized elements.

latest-news-card-1
Human Drugs

CGMP Violations at TJA Health

FDA warns Joliet, IL-based TJA Health about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

Quality CDMO Marketing Unapproved Drugs: FDA

FDA warns Fort Worth, TX-based Quality CDMO that it is marketing five unapproved new drugs.

latest-news-card-1
Human Drugs

Consider Phased DSCSA Enforcement: PhRMA

PhRMA asks FDA to consider a phased approach to enforcing the Drug Supply Chain Security Act because many drug company trading partners may not be rea...